Clinical Trials Browser

Phase 1/2 × INDUSTRY × Trifluridine × Clear all

NCT05405595 2026-01-07

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT06873763 2025-07-11

Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer

Phase 1/2 Recruiting

Gastrointestinal

Colorectal Neoplasms